Nephrology Unit, Department of Medicine, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia.
J Clin Nurs. 2012 Oct;21(19-20):2879-85. doi: 10.1111/j.1365-2702.2012.04091.x. Epub 2012 May 31.
The main objective of the study was to correlate the target dry weight in haemodialysis (HD) patients as assessed clinically by nephrologists to those measured by the Body Composition Monitor (BCM - Fresenius) machine. The second objective was to compare pre and postdialysis changes of extracellular fluid and clinical parameters.
Clinical assessment of target dry weight in HD patients remains problematic. Inaccurate dry weight resulted in hypovolaemic or overhydration states. The BCM (Fresenius) utilises bioimpedance technology for body fluid monitoring and has been extensively validated.
This was a prospective cross-sectional study on consecutive patients who underwent HD and gave informed consent. Methods. The target dry weights of these patients were first assessed by their attending nephrologists and appropriate ultrafiltration prescribed. Their body fluid statuses were then measured with the BCM before and after HD treatment.
Eighty HD patients (37 men, 43 women) with a mean age of 55 ± 13 years and a mean duration on HD of 71 ± 56 months were studied. The dry weight measured by BCM significantly correlated with dry weight assessed by the nephrologists. The mean dry weight was higher when assessed by the nephrologists compared to that by BCM. Only systolic blood pressure and not other components of blood pressure reduced after HD treatments.
The BCM is a rapid and easy-to-use tool that can help HD nursing staffs to adjust patients' dry weights between nephrologists' reviews thus optimising HD therapy and patient outcomes.
We propose that experienced HD nursing staff be trained in the use of the BCM or other simple bioimpedance machines to help monitor patient overhydration and approximate dry weight in consultation with the nephrologists responsible for the care of these patients so as to obviate excessive residual overhydration between nephrology reviews.
本研究的主要目的是将肾病学家临床评估的血液透析(HD)患者的目标干体重与身体成分监测仪(BCM - 费森尤斯)测量的干体重进行相关分析。第二个目标是比较细胞外液和临床参数的透析前后变化。
HD 患者目标干体重的临床评估仍然存在问题。不准确的干体重会导致低血容量或水过多状态。BCM(费森尤斯)利用生物阻抗技术进行体液监测,并已得到广泛验证。
这是一项连续接受 HD 治疗并知情同意的患者的前瞻性横断面研究。方法。这些患者的目标干体重首先由他们的主治肾病医生评估,并开出适当的超滤量。然后,在 HD 治疗前后,用 BCM 测量他们的体液状态。
共纳入 80 例 HD 患者(37 名男性,43 名女性),平均年龄 55±13 岁,HD 治疗时间平均 71±56 个月。BCM 测量的干体重与肾病医生评估的干体重显著相关。与 BCM 相比,肾病医生评估的干体重更高。只有收缩压而不是其他血压成分在 HD 治疗后降低。
BCM 是一种快速易用的工具,可以帮助 HD 护理人员在肾病医生复查之间调整患者的干体重,从而优化 HD 治疗和患者预后。
我们建议经验丰富的 HD 护理人员接受 BCM 或其他简单生物阻抗仪的使用培训,以帮助监测患者的水过多并在与负责这些患者护理的肾病医生协商时近似干体重,以避免在肾病医生复查之间出现过多的残留水过多。